FDA, Drug Ads

FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new guidelines, which have been over 15 years in the making, are designed to end industry practices that downplay or distract viewers from risk information.
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon, distracting visuals or audio effects. A 2007 law directed the FDA to ensure that drug risk information appears “in a clear, conspicuous and neutral manner.”
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers from knowing risk information about drugs.
FDA puts new restrictions on TV ads for drugs
The U.S. Food and Drug Administration spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay or distract viewers from risk information. Many companies have already adopted the rules ...
FDA rule on TV drug ads: compliance boon or comprehension bust?
Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but should aid in drugmakers’ ability to meet the fair-balance standard.
JD Supra13h
FDA Advisory Committee outlines informed consent best practices
The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...
ConsumerAffairs7d
FDA proposes removing popular decongestant found in cold meds
The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy ...
FiercePharma19h
FDA slams Merz over 'misleading' Instagram ad for Botox rival
A strand of Merz Pharmaceuticals’ star-studded promotion of the anti-wrinkle drug Xeomin has landed it a reprimand from the ...
Hosted on MSN1d
Intercept loses Ocaliva FDA full approval bid in rare liver disease
The FDA said it was “unable to approve the supplemental new drug application (sNDA ... a post-marketing study called ...
Dog parents want arthritis drug pulled from shelves after being linked to hundreds of pet deaths
Instead, they’re left wondering how their pets ended up hurt or dead, after getting a shot that was supposed to give them new ...
The FDA wants these cold medicines off the shelves. Should Canada follow?
The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...
Aldeyra's FDA Resubmission And AbbVie Option Revitalize Reproxalap's Prospects
Aldeyra received an FDA CRL for reproxalap, necessitating an additional study for DED approval. Read why I continue to rate ...